Anifrolumab for Hidradenitis Suppurativa
Conditions: Hidradenitis Suppurativa; Acne Inversa; Hidradenitis Interventions: Drug: Anifrolumab Sponsors: University of North Carolina, Chapel Hill; AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Pathophysiological Basis of Hidradenitis Suppurativa
Conditions: Hidradenitis Suppurativa Interventions: Procedure: excision Sponsors: Clinical Hospital Center Rijeka Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Bacteriophage Therapy for Difficult-to-treat Infections: the Implementation of a Multidisciplinary Phage Task Force
Conditions: Musculoskeletal Infection; Chronic Rhinosinusitis (Diagnosis); Sepsis; Pulmonary Infection; Hidradenitis Suppurativa Interventions: Other: Prospective data collection; Other: Prospective data collection Sponsors: Universitaire Ziekenhuizen KU Leuven; KU Leuven Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
Conditions: Hidradenitis Suppurativa Interventions: Biological: SBT777101 Sponsors: Sonoma Biotherapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Defects of Keratinocytes Function in Dermatologic Patients
Conditions: Hidradenitis Suppurativa Sponsors: IRCCS Burlo Garofolo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
A Study to Demonstrate the Safety and Efficacy of Siplizumab in the Treatment of Hidradenitis Suppurativa
Conditions: Hidradenitis Suppurativa Interventions: Drug: Siplizumab Sponsors: University of Alabama at Birmingham; ITB-Med LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases
Conditions: Psoriasis; Alopecia Areata; Hidradenitis Suppurativa; Vitiligo; Atopic Dermatitis Interventions: Behavioral: HautKompass Sponsors: Universit ätsklinikum Hamburg-Eppendorf; German Federal Ministry of Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa
Conditions: Hidradenitis Suppurativa Interventions: Drug: TIRZEPATIDE Sponsors: Florida Academic Centers Research and Education, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab
Conditions: Hidradenitis Suppurativa (HS) Interventions: Drug: Spesolimab Sponsors: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Botulinum Toxin-A for Hidradenitis Suppurativa
Conditions: Hidradenitis Suppurativa; Hidradenitis Suppurativa \(HS\); Hidradenitis Suppurativa, Acne Inversa Interventions: Drug: Normal saline; Drug: Botulinum toxin type A Sponsors: Yale University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
Conditions: Hidradenitis Suppurativa (HS) Interventions: Drug: Povorcitinib Sponsors: Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa
Conditions: Hidradenitis Suppurativa Sponsors: Power Life Sciences Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Lutikizumab Showed Positive Results in a Phase 2 Trial of Adults with Moderate to Severe Hidradenitis Suppurativa as Program Advances to Phase 3
NORTH CHICAGO, Ill., Jan. 8, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced Phase 2 results showing adults with moderate to severe hidradenitis suppurativa (HS) who had previously failed anti-TNF therapy who received lutikizumab (ABT-981)... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 8, 2024 Category: Pharmaceuticals Source Type: clinical trials
Mindfulness in Hidradenitis Suppurativa
Conditions: Hidradenitis Suppurativa Interventions: Behavioral: Mindfulness Based Stress reduction Sponsors: University of Arkansas Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Conditions: Hidradenitis Interventions: Drug: Amlitelimab; Drug: Placebo Sponsors: Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
